BsUFA III Negotiations Nearly Done; Commitment Letter Being Written

 
• By Derrick Gingery

Supplement approval timeline and regulatory science issues apparently have been resolved.

FDA website
When BsUFA III talks end, only the generic drug user fee reauthorization negotiations will remain ongoing. • Source: Alamy

More from Biosimilars

More from Biosimilars & Generics